1. Home
  2. VREX vs NBY Comparison

VREX vs NBY Comparison

Compare VREX & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Varex Imaging Corporation

VREX

Varex Imaging Corporation

HOLD

Current Price

$13.53

Market Cap

580.6M

Sector

Technology

ML Signal

HOLD

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$0.55

Market Cap

398.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
VREX
NBY
Founded
2016
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
580.6M
398.2M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
VREX
NBY
Price
$13.53
$0.55
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$16.67
N/A
AVG Volume (30 Days)
420.5K
1.9M
Earning Date
02-10-2026
04-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.47
Revenue
$854,400,000.00
$10,302,000.00
Revenue This Year
$4.78
$23.91
Revenue Next Year
$4.16
$32.05
P/E Ratio
N/A
$23.40
Revenue Growth
4.09
390.34
52 Week Low
$6.76
$0.46
52 Week High
$14.57
$19.95

Technical Indicators

Market Signals
Indicator
VREX
NBY
Relative Strength Index (RSI) 45.72 35.04
Support Level $12.00 $0.57
Resistance Level $14.39 $0.72
Average True Range (ATR) 0.61 0.32
MACD -0.14 -0.21
Stochastic Oscillator 53.83 1.54

Price Performance

Historical Comparison
VREX
NBY

About VREX Varex Imaging Corporation

Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: